This review explores microfluidic technology and 3D bioprinting, highlighting their applications in cancer treatment and diagnostic biomarker discovery.
Key Points
Microfluidic technology enables more relevant tumor models, improving research outcomes in oncology.
The integration of 3D bioprinting facilitates precise control over the tumor microenvironment and biomarker discovery.
Key challenges include ensuring material biocompatibility and developing scalable fabrication methods.
Future directions focus on multi-organ-on-chip systems and AI-enhanced analytical frameworks.